According to GuruFocus Insider Data, the recent chief financial officer sells were: Alcoa Corp. (AA, Financial) and Vertex Pharmaceuticals Inc. (VRTX, Financial).
Alcoa CFO sold 229,475 shares
Executive Vice President and CFO William F. Oplinger sold 229,475 shares for $52.86 per share on Jan. 22. Since then, the stock price has increased by 3.01%. Alcoa has a market cap of $10.08 billion and its shares were trading around $54.45 on Monday. The company has a price-earnings ratio of 47.31 and a price-sales ratio of 0.86.
Alcoa announced its third-quarter 2017 results with revenues of $2.96 billion and gross profit of $603 million. The net income was $113 million. The company's 2016 total revenue was $9.32 billion, a 17% decrease from 2015. The 2016 gross profit was $1.43 billion, a 37% decrease from the year prior. The net loss in 2016 was $400 million.
Vertex Pharmaceuticals CFO sold 777 shares
CFO Thomas Graney sold 777 shares for $149.95 per share on Jan. 2. Since then, the stock price has increased by 11.63%. Vertex has a market cap of $42.33 billion and its shares were trading around $167.39 on Monday. The company has a price-earnings ratio of 214.61 and a price-sales ratio of 18.16.
Vertex announced its third-quarter results with revenue of $578.17 million and gross profit of $505.29 million, while the net loss was $102.95 million. The company's 2016 total revenue was $1.7 billion, a 65% increase from 2015. The gross profit in 2016 was $1.49 billion, a 64% increase from the year prior. The net loss in 2016 was $112.05 million.
CEO and President Jeffrey M. Leiden sold 99,563 shares for $156.99 per share on Jan. 16. Since then, the stock price has increased by 6.62%. Executive Vice President and Chief Commercial Officer Stuart A. Arbuckle sold 8,969 shares for $169 per share on Jan. 24. Since then, the stock price has fallen 0.95%. Director Margaret G. McGlynn sold 20,000 shares for $162.5 per share on Jan. 23. Since then, the stock price has increased by 3.01%.
Disclosure: None.
